Citations 1
Oral Vancomycin as an Emerging Therapy for Inflammatory Pouch Conditions Associated With Primary Sclerosing Cholangitis
Dunleavy, Katie A. , Meyers, Abigail , Violante, Tommaso , Kassmeyer, Blake , Coelho–Prabhu, Nayantara , Raffals, Laura E. , Larson, David W. , Dunleavy, Katie , Urquhart, Siri A. , Coelho-Prabhu, Nayantara , Raffals, Laura , Larson, David W , Violante, Tommaso , Meyers, Abigail
Inflammatory Bowel Diseases | June 30, 2025 | Volume: 31 | Issue: 9 | Pages: 2597-2601
Lay Summary Oral vancomycin shows promise in treating pouchitis in patients with primary sclerosing cholangitis and ulcerative colitis. In this study, vancomycin helped reduce stool frequency, urgency, and incontinence. More research is needed to confirm its long-term benefits and best treatment practices.